Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) can be injected into three sites on your body: the abdomen, the front of the thigh, or the outer upper arm. Each site works equally well for subcutaneous delivery, and rotating between them helps protect the skin from irritation. Mounjaro is a prescription-only medicine; a clinician decides whether it is right for you before treatment begins. Once you are set up with a prescriber and familiar with your injection routine, choosing where to inject becomes second nature — and our overview of how the Mounjaro pen works covers the full injection process if you want to read ahead.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you receive your first Mounjaro pen, your prescriber will have discussed where to inject. The three approved sites are the abdomen (stomach area), the front of either thigh, and the outer upper arm, and you can find a full breakdown of each on our page about where to give Mounjaro shots. All three deliver tirzepatide into the subcutaneous fat layer just beneath the skin, where the medicine is absorbed steadily.
Rotation is not optional housekeeping, it is clinically important. Injecting repeatedly into the same small patch of skin can cause lipohypertrophy, a build-up of fatty tissue that changes the local texture and can slow or alter how the medicine absorbs. The simple rule is to move to a different area each week: abdomen one week, thigh the next, upper arm the week after, then back around. Within each site, shift a couple of centimetres from where you injected last time.
Some people find it helpful to keep a brief note (even just a word in a calendar app) of where they injected that week. It sounds fussy, but a weekly injection schedule means the rotation genuinely matters. If you order on a Monday every four weeks, pairing the site note with your delivery reminder is an easy way to track it.
The Mounjaro treatment page has a broader picture of what to expect across the full treatment course.
Whichever site you choose, the preparation is the same. Clean the skin with a small alcohol swab and allow it to dry completely before injecting, damp skin can sting and the alcohol needs a moment to evaporate. Alcohol swabs designed for injection preparation are available if you need a reliable supply.
For the abdomen, aim for the soft fatty tissue to the side of your navel (at least 2 cm away from it) and avoid the belt line or any area where clothing rubs. The abdomen is most people's first choice because there is usually a comfortable amount of subcutaneous tissue and the angle is easy to manage with one hand.
For the thigh, use the middle third of the front or outer thigh. Avoid the inner thigh, where the skin is thinner and more sensitive. Sitting down and letting the muscle relax makes the injection more comfortable.
The outer upper arm is the trickiest to reach alone. Most people who use this site have a partner or carer help them. If you self-inject here, use a mirror and take your time positioning the pen, a rushed angle risks a shallow injection. Your prescriber can walk you through the technique; there is also detailed guidance in the Patient Information Leaflet that comes with every pen.
For everything related to keeping your pen in the best condition between doses, our page on storing your Mounjaro pen covers temperature, travel, and what to do if the pen has been left out.
A small amount of redness, mild tenderness, or a tiny bruise at the injection site is common and usually resolves within a day or two. These reactions tend to be most noticeable in the first few weeks of treatment, before your technique becomes consistent.
Contact your prescriber or GP if you notice a firm lump or swelling that does not fade within a couple of weeks, this can indicate lipohypertrophy and is a signal to change your rotation pattern. Avoid injecting into that area until it resolves. Any signs of infection (increasing redness, warmth, discharge, or fever) need prompt medical attention.
Generalised reactions (rash away from the injection site, facial swelling, difficulty breathing) are uncommon but require emergency care. The NHS tirzepatide medicines page includes full guidance on side effects and when to seek help, and is worth bookmarking for reference.
It is also worth knowing that what happens locally at the injection site is only part of the picture. Understanding how Mounjaro affects the body more broadly can help you make sense of other changes you notice during treatment.
Correct injection technique is one of the things a prescriber covers at the start of treatment, it is not something you should have to piece together from scratch. At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day you submit it. They are a real clinician, not software, and they can answer site-specific questions during aftercare.
Used sharps must be disposed of safely. A sharps container is the correct way to do this; never put used needles in a household bin. Your local pharmacy or GP surgery can advise on your council's sharps collection service.
If you are curious about what the private treatment pathway looks like in terms of cost, our Mounjaro pricing page sets out what is included in a single transparent price. And if you have questions about whether you are eligible, our prescribers are the right people to ask, start your free consultation to find out.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.